Syndax Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US87164F1057
USD
20.25
9.16 (82.6%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1161327,
    "name": "Syndax Pharmaceuticals, Inc.",
    "stock_name": "Syndax Pharmaceuticals, Inc.",
    "full_name": "Syndax Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/syndax-pharmaceuticals-inc",
    "exchange": 1,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "20.25",
    "chg": 9.16,
    "chgp": "82.6%",
    "dir": 1,
    "prev_price": "11.09",
    "mcapval": "1,783.49",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US87164F1057",
    "curr_date": "Jan 23",
    "curr_time": "",
    "bse_nse_vol": "2.17 M",
    "exc_status": "Active",
    "traded_date": "Jan 23, 2026",
    "traded_date_str": "2026 01 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/syndax-pharmaceuticals-inc-1161327-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Syndax Pharmaceuticals Hits Day Low at $13.03 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syndax-pharmaceuticals-hits-day-low-at-1303-amid-price-pressure-3649338",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/SyndaxPharmaceu_priceRelatedfactors_3649338.png",
        "date": "2025-10-27 17:39:19",
        "description": "Syndax Pharmaceuticals, Inc. faced a notable decline in stock performance, reflecting ongoing challenges and negative results over 11 consecutive quarters. The company's one-year performance shows a significant drop, contrasting with broader market gains. Despite slight promoter confidence, Syndax's market position remains precarious within the pharmaceuticals sector."
      },
      {
        "title": "Syndax Pharmaceuticals Experiences Revision in Stock Evaluation Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syndax-pharmaceuticals-technical-trend-shifts-from-bullish-to-mildly-bullish-amid-stock-price-decline-3649007",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/SyndaxPharmaceu_technicaldot_3649007.png",
        "date": "2025-10-27 15:44:23",
        "description": "Syndax Pharmaceuticals, Inc. has experienced significant stock fluctuations, currently priced at $13.53, down from a 52-week high of $22.50. The company has underperformed compared to the S&P 500 over the past year and three years, indicating ongoing challenges in the biotechnology sector."
      }
    ],
    "total": 10,
    "sid": "1161327",
    "stock_news_url": "https://www.marketsmojo.com/news/syndax-pharmaceuticals-inc-1161327"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available